Growth Metrics

Edwards Lifesciences (EW) Liabilities from Discontinued Operations (2023 - 2025)

Edwards Lifesciences has reported Liabilities from Discontinued Operations over the past 3 years, most recently at 200000.0 for Q3 2025.

  • Quarterly results put Liabilities from Discontinued Operations at 200000.0 for Q3 2025, down 88.89% from a year ago — trailing twelve months through Sep 2025 was 200000.0 (down 88.89% YoY), and the annual figure for FY2024 was 2000000.0, down 92.03%.
  • Liabilities from Discontinued Operations for Q3 2025 was 200000.0 at Edwards Lifesciences, down from 2300000.0 in the prior quarter.
  • Over the last five years, Liabilities from Discontinued Operations for EW hit a ceiling of 30000000.0 in Q2 2024 and a floor of 200000.0 in Q3 2025.
  • Median Liabilities from Discontinued Operations over the past 3 years was 2300000.0 (2025), compared with a mean of 9100000.0.
  • Peak annual rise in Liabilities from Discontinued Operations hit 88.89% in 2025, while the deepest fall reached 92.33% in 2025.
  • Edwards Lifesciences' Liabilities from Discontinued Operations stood at 25100000.0 in 2023, then tumbled by 92.03% to 2000000.0 in 2024, then plummeted by 90.0% to 200000.0 in 2025.
  • The last three reported values for Liabilities from Discontinued Operations were 200000.0 (Q3 2025), 2300000.0 (Q2 2025), and 2300000.0 (Q1 2025) per Business Quant data.